News & Media
Diabetes Center looks brightly into the future when it will in large part move into the new Barbara and Gerson Bakar Research and Academic Building, along with other research programs for cancer...
Critical Path Institute's Translational Therapeutics Accelerator program, designed to support academic researchers in traversing the drug development valley of death and advancing new cutting-edge...
The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutes dedicated to regenerative medicine, granted over $22.5 million to nine projects through the Quest...
For more than half a century, the W.M. Keck Foundation has funded projects that are distinctive and novel in their approach, question the prevailing paradigm, and have the potential to break open new...
Diabetes Center Director Mark Anderson MD PhD has been awarded the prestigious Coley Award from the Cancer Research Institute. The Coley Award honors groundbreaking contributions to cancer research...
We had our annual Diabetes Academy, a special event which brings together our researchers, clinicians, supporter, and patients to explore groundbreaking diabetes research and treatments and hear new...
Mark Anderson, MD, PhD accepts the prestigious 2024 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, which recognizes the groundbreaking discoveries in immune tolerance...
Shylaja Srinivasan, MD, discusses the importance of bringing awareness and addressing stigmas related to type 2 diabetes in children. Shylaja Srinivasan is a pediatric endocrinologist who cares for...
Is Ozempic too good to be true? How does it work? Is it safe for everyone? What happens when you stop taking it? Our panel of UCSF experts explore the root causes of excess weight, how weight-loss...
Jeff Bluestone presents "Immune Tolerance: Traveling on the long road towards finding the Holy Grail" at our 20th Year Anniversary Symposium